Trial · NCT04724837
Results by group46
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 46
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Change in Urinary Albumin to Creatinine Ratio (UACR) From Baseline to Week 12 | Zibotentan 1.5 mg + Dapagliflozin | 0.48 | Standard Error 1.094 | milligram/gram (mg/g) | |
| Change in Urinary Albumin to Creatinine Ratio (UACR) From Baseline to Week 12 | Placebo + Dapagliflozin | 0.72 | Standard Error 1.090 | milligram/gram (mg/g) | |
| Change in UACR From Baseline to Week 12 | Zibotentan 0.25 mg + Dapagliflozin | 0.52 | Standard Error 1.106 | mg/g | |
| Change in UACR From Baseline to Week 12 | Placebo + Dapagliflozin | 0.72 | Standard Error 1.090 | mg/g | |
| Change in Office Systolic Blood Pressure From Baseline to Week 12 | Zibotentan 0.25 mg + Dapagliflozin | -7.1 | 90% Confidence Interval -10.0 to -4.1 | Millimeters of mercury (mmHg) | |
| Change in Office Systolic Blood Pressure From Baseline to Week 12 | Zibotentan 1.5 mg + Dapagliflozin | -11.0 | 90% Confidence Interval -13.5 to -8.4 | Millimeters of mercury (mmHg) | |
| Change in Office Systolic Blood Pressure From Baseline to Week 12 | Placebo + Dapagliflozin | -3.4 | 90% Confidence Interval -5.8 to -1.0 | Millimeters of mercury (mmHg) | |
| Change in Office Diastolic Blood Pressure From Baseline to Week 12 | Zibotentan 0.25 mg + Dapagliflozin | -4.3 | 90% Confidence Interval -6.2 to -2.5 | mmHg | |
| Change in Office Diastolic Blood Pressure From Baseline to Week 12 | Zibotentan 1.5 mg + Dapagliflozin | -6.8 | 90% Confidence Interval -8.4 to -5.2 | mmHg | |
| Change in Office Diastolic Blood Pressure From Baseline to Week 12 | Placebo + Dapagliflozin | -1.4 | 90% Confidence Interval -2.9 to 0.1 | mmHg | |
| Change in UACR From Baseline to Week 12 | Zibotentan 0.25 mg + Dapagliflozin | 0.52 | Standard Error 1.106 | mg/g | |
| Change in UACR From Baseline to Week 12 | Zibotentan 1.5 mg + Dapagliflozin | 0.48 | Standard Error 1.094 | mg/g | |
| Change in UACR From Baseline to Week 12 | Placebo + Dapagliflozin | 0.72 | Standard Error 1.090 | mg/g | |
| Change in eGFR From Baseline to Week 1, Week 12, and Week 14 | Zibotentan 0.25 mg + Dapagliflozin | Week 1 | -2.0 | 90% Confidence Interval -3.5 to -0.5 | milliliters/minutes/1.73 square metres |
| Change in eGFR From Baseline to Week 1, Week 12, and Week 14 | Zibotentan 1.5 mg + Dapagliflozin | Week 1 | -3.9 | 90% Confidence Interval -5.2 to -2.6 | milliliters/minutes/1.73 square metres |
| Change in eGFR From Baseline to Week 1, Week 12, and Week 14 | Placebo + Dapagliflozin | Week 1 | -3.1 | 90% Confidence Interval -4.4 to -1.8 | milliliters/minutes/1.73 square metres |
| Change in eGFR From Baseline to Week 1, Week 12, and Week 14 | Zibotentan 0.25 mg + Dapagliflozin | Week 12 | -3.1 | 90% Confidence Interval -4.7 to -1.5 | milliliters/minutes/1.73 square metres |
| Change in eGFR From Baseline to Week 1, Week 12, and Week 14 | Zibotentan 1.5 mg + Dapagliflozin | Week 12 | -3.0 | 90% Confidence Interval -4.4 to -1.6 | milliliters/minutes/1.73 square metres |
| Change in eGFR From Baseline to Week 1, Week 12, and Week 14 | Placebo + Dapagliflozin | Week 12 | -1.9 | 90% Confidence Interval -3.3 to -0.6 | milliliters/minutes/1.73 square metres |
| Change in eGFR From Baseline to Week 1, Week 12, and Week 14 | Zibotentan 0.25 mg + Dapagliflozin | Week 14 | 0.2 | 90% Confidence Interval -1.4 to 1.8 | milliliters/minutes/1.73 square metres |
Source ClinicalTrials.govtrials-2026-11-12-0.4.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04724837/results